Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, Chapel Hill.
Duke Clinical Research Institute.
Med Care. 2020 May;58(5):433-444. doi: 10.1097/MLR.0000000000001299.
Opioids are prescribed more frequently than nonpharmacologic treatments for persistent musculoskeletal pain (MSP). We estimate the association between the supply of physical therapy (PT) and mental health (MH) providers and early nonpharmacologic service use with high-risk opioid prescriptions among Medicare beneficiaries with persistent MSP.
We retrospectively studied Medicare beneficiaries (>65 y) enrolled in Fee-for-Service and Part D (2007-2014) with a new persistent MSP episode and no opioid prescription during the prior 6 months. Independent variables were nonpharmacologic provider supply per capita and early nonpharmacologic service use (any use during first 3 mo). One year outcomes were long-term opioid use (LTOU) (≥90 days' supply) and high daily dose (HDD) (≥50 mg morphine equivalent). We used multinomial regression and generalized estimating equations and present adjusted odds ratios (aORs).
About 2.4% of beneficiaries had LTOU; 11.9% had HDD. The supply of MH providers was not associated with LTOU and HDD. Each additional PT/10,000 people/county was associated with greater odds of LTOU [aOR: 1.06; 95% confidence interval (CI), 1.01-1.11). Early MH use was associated with lower odds of a low-risk opioid use (aOR: 0.81; 95% CI, 0.68-0.96), but greater odds of LTOU (aOR: 1.93; 95% CI, 1.28-2.90). Among beneficiaries with an opioid prescription, early PT was associated with lower odds of LTOU (aOR: 0.75; 95% CI, 0.64-0.89), but greater odds of HDD (aOR: 1.25; 95% CI, 1.15-1.36).
The benefits of nonpharmacologic services on opioid use may be limited. Research on effective delivery of nonpharmacologic services to reduce high-risk opioid use for older adults with MSP is needed.
阿片类药物比非药物治疗更频繁地用于治疗持续性肌肉骨骼疼痛(MSP)。我们估计,物理治疗(PT)和心理健康(MH)提供者的供应以及早期非药物服务的使用与 Medicare 受益人的持续性 MSP 之间与高风险阿片类药物处方相关。
我们回顾性研究了参加 Fee-for-Service 和 Part D(2007-2014 年)的 Medicare 受益人(>65 岁),他们患有新的持续性 MSP 发作,并且在过去 6 个月内没有服用阿片类药物。独立变量为每千人的非药物提供者供应量和早期非药物服务的使用情况(在最初 3 个月内的任何使用)。一年的结果是长期使用阿片类药物(LTOU)(≥90 天供应量)和高日剂量(HDD)(≥50mg 吗啡当量)。我们使用多项回归和广义估计方程,并呈现调整后的优势比(aOR)。
约有 2.4%的受益人有 LTOU;11.9%的人有 HDD。MH 提供者的供应与 LTOU 和 HDD 无关。每增加 10,000 人/县的 PT/人,LTOU 的可能性就会增加[OR:1.06;95%置信区间(CI),1.01-1.11]。早期 MH 使用与低风险阿片类药物使用的可能性降低相关(OR:0.81;95%CI,0.68-0.96),但与 LTOU 的可能性增加相关(OR:1.93;95%CI,1.28-2.90)。在有阿片类药物处方的受益人中,早期 PT 与 LTOU 的可能性降低相关(OR:0.75;95%CI,0.64-0.89),但与 HDD 的可能性增加相关(OR:1.25;95%CI,1.15-1.36)。
非药物服务对阿片类药物使用的益处可能有限。需要研究为老年 MSP 患者提供有效非药物服务以减少高风险阿片类药物使用的方法。